Glyphase-MV 2/0.2 Tablet SR
Marketer
Griffins Life Sciences Pvt. Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glyphase-MV 2/0.2 Tablet SR
Metformin/glimepiride extended-release tablets are classified as antidiabetic agents, a combination medication for managing type 2 diabetes in adults. This treatment helps regulate blood glucose levels. These tablets should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-managed blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of complications including kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms such as sweating, lightheadedness, headache, and tremors. Prompt recognition and treatment are vital; maintaining consistent meals and carrying a fast-acting glucose source (e.g., sugary snacks or juice) are preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other potential adverse effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to evaluate blood cell counts and liver function.
Primary Ingredients of Glyphase-MV 2/0.2 Tablet SR
No text provided. Please provide the text you want me to rephrase.
Uses of Glyphase-MV 2/0.2 Tablet SR
Managing type 2 diabetes
Major Benefits of Glyphase-MV 2/0.2 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glyphase-MV 2/0.2 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Glyphase-MV 2/0.2 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glyphase-MV 2/0.2 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glyphase-MV 2/0.2 Tablet SR whole; do not crush, chew, or divide it. Administer on an empty stomach.
How Glyphase-MV 2/0.2 Tablet SR works:
Glyphase-MV 2/0.2 extended-release tablets contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glyphase-MV 2/0.2 Tablet SR and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glyphase-MV 2/0.2 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glyphase-MV 2/0.2 tablet is likely not safe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glyphase-MV 2/0.2 Tablet SR is discouraged in individuals with kidney impairment, and contraindicated in those with severe kidney disease. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Glyphase-MV 2/0.2 Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. In those with mild to moderate liver disease, Glyphase-MV 2/0.2 Tablet SR therapy typically begins with a low dose; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glyphase-MV 2/0.2 Tablet SR :
Should you forget a Glyphase-MV 2/0.2 Tablet SR dose, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glyphase-MV 2/0.2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently